Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study |
| |
| Affiliation: | 1. Department of Oncology, St Jude Children''s Research Hospital, Memphis, TN, USA;2. Department of Cell and Molecular Biology, St Jude Children''s Research Hospital, Memphis, TN, USA;3. Department of Biostatistics, St Jude Children''s Research Hospital, Memphis, TN, USA;4. Department of Psychology, St Jude Children''s Research Hospital, Memphis, TN, USA;5. Department of Infectious Diseases, St Jude Children''s Research Hospital, Memphis, TN, USA;6. Department of Pathology, St Jude Children''s Research Hospital, Memphis, TN, USA;7. Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA;8. AbbVie, North Chicago, IL, USA;9. Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt;10. Department of Pediatrics, Stanford University, Palo Alto, CA, USA |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
